Treatment of Ciprofloxacin Nonsusceptible Urinary Tract Infections with Ciprofloxacin

Wagenlehner FM Niemetz AH Weidner W Naber KG . Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Int J Antimicrob Agents 2008;31:S25–34.

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19, 19th ed. Clinical and Laboratory Standards Institute, Wayne, PA. 2009.

Navarro MD Sanchez Milano CC Castaneda AZ Marinero ML Sayalero Sanchez-Navarro A . Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients. Clin Pharmacokinet 2002;41:1213–20.

Forrest A Nix DE Ballow CH Goss TF Birmingham MC Schentag JJ . Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993;37:1073–81.

Neuhauser MM Weinstein RA Rydman R Danziger LH Karam G Quinn JP . Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003;289:885–8.